388 related articles for article (PubMed ID: 12183361)
1. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.
Conacci-Sorrell ME; Ben-Yedidia T; Shtutman M; Feinstein E; Einat P; Ben-Ze'ev A
Genes Dev; 2002 Aug; 16(16):2058-72. PubMed ID: 12183361
[TBL] [Abstract][Full Text] [Related]
2. The shed ectodomain of Nr-CAM stimulates cell proliferation and motility, and confers cell transformation.
Conacci-Sorrell M; Kaplan A; Raveh S; Gavert N; Sakurai T; Ben-Ze'ev A
Cancer Res; 2005 Dec; 65(24):11605-12. PubMed ID: 16357171
[TBL] [Abstract][Full Text] [Related]
3. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin.
Simcha I; Shtutman M; Salomon D; Zhurinsky J; Sadot E; Geiger B; Ben-Ze'ev A
J Cell Biol; 1998 Jun; 141(6):1433-48. PubMed ID: 9628899
[TBL] [Abstract][Full Text] [Related]
4. Wnt-3A/beta-catenin signaling induces transcription from the LEF-1 promoter.
Filali M; Cheng N; Abbott D; Leontiev V; Engelhardt JF
J Biol Chem; 2002 Sep; 277(36):33398-410. PubMed ID: 12052822
[TBL] [Abstract][Full Text] [Related]
5. Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells.
Sekiya T; Adachi S; Kohu K; Yamada T; Higuchi O; Furukawa Y; Nakamura Y; Nakamura T; Tashiro K; Kuhara S; Ohwada S; Akiyama T
J Biol Chem; 2004 Feb; 279(8):6840-6. PubMed ID: 14660579
[TBL] [Abstract][Full Text] [Related]
6. PML is a target gene of beta-catenin and plakoglobin, and coactivates beta-catenin-mediated transcription.
Shtutman M; Zhurinsky J; Oren M; Levina E; Ben-Ze'ev A
Cancer Res; 2002 Oct; 62(20):5947-54. PubMed ID: 12384561
[TBL] [Abstract][Full Text] [Related]
7. Differential mechanisms of LEF/TCF family-dependent transcriptional activation by beta-catenin and plakoglobin.
Zhurinsky J; Shtutman M; Ben-Ze'ev A
Mol Cell Biol; 2000 Jun; 20(12):4238-52. PubMed ID: 10825188
[TBL] [Abstract][Full Text] [Related]
8. Functional diversity of Xenopus lymphoid enhancer factor/T-cell factor transcription factors relies on combinations of activating and repressing elements.
Gradl D; König A; Wedlich D
J Biol Chem; 2002 Apr; 277(16):14159-71. PubMed ID: 11821382
[TBL] [Abstract][Full Text] [Related]
9. Dynamic expression of Lef/Tcf family members and beta-catenin during chick gastrulation, neurulation, and early limb development.
Schmidt M; Patterson M; Farrell E; Münsterberg A
Dev Dyn; 2004 Mar; 229(3):703-7. PubMed ID: 14991726
[TBL] [Abstract][Full Text] [Related]
10. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
11. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line.
Maeda O; Usami N; Kondo M; Takahashi M; Goto H; Shimokata K; Kusugami K; Sekido Y
Oncogene; 2004 Jan; 23(4):964-72. PubMed ID: 14661054
[TBL] [Abstract][Full Text] [Related]
12. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.
Leung JY; Kolligs FT; Wu R; Zhai Y; Kuick R; Hanash S; Cho KR; Fearon ER
J Biol Chem; 2002 Jun; 277(24):21657-65. PubMed ID: 11940574
[TBL] [Abstract][Full Text] [Related]
13. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S
Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679
[TBL] [Abstract][Full Text] [Related]
14. Keratinocyte adherens junctions initiate nuclear signaling by translocation of plakoglobin from the membrane to the nucleus.
Hu P; Berkowitz P; O'Keefe EJ; Rubenstein DS
J Invest Dermatol; 2003 Aug; 121(2):242-51. PubMed ID: 12880414
[TBL] [Abstract][Full Text] [Related]
15. SKI activates Wnt/beta-catenin signaling in human melanoma.
Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
[TBL] [Abstract][Full Text] [Related]
16. T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with beta-catenin to coactivate C/EBPalpha and steroidogenic factor 1 transcription factors.
Kennell JA; O'Leary EE; Gummow BM; Hammer GD; MacDougald OA
Mol Cell Biol; 2003 Aug; 23(15):5366-75. PubMed ID: 12861022
[TBL] [Abstract][Full Text] [Related]
17. PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter.
Vadlamudi U; Espinoza HM; Ganga M; Martin DM; Liu X; Engelhardt JF; Amendt BA
J Cell Sci; 2005 Mar; 118(Pt 6):1129-37. PubMed ID: 15728254
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
[TBL] [Abstract][Full Text] [Related]
19. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.
Porfiri E; Rubinfeld B; Albert I; Hovanes K; Waterman M; Polakis P
Oncogene; 1997 Dec; 15(23):2833-9. PubMed ID: 9419974
[TBL] [Abstract][Full Text] [Related]
20. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
Jung HC; Kim K
Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]